Yonatan Malca
CIK: 0001904759
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Malca Yonatan
Malca Yonatan (SEC CIK 0001904759) files insider reports with the SEC as Director of Entera Bio Ltd. (ENTX) and Director of IceCure Medical Ltd. (ICCM).
Signal8 holds 5 ownership filings by Malca Yonatan (1 Form 3, 4 Form 4), filed between Oct 4, 2024 and Aug 7, 2026. Those filings report 4 transactions, from Oct 2, 2024 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Malca Yonatan's filings is in JERUSALEM.
Recent filings by Malca Yonatan
Other insiders filing for Entera Bio Ltd. (ENTX)
- Camisasca Riccardo Paolo, Chief Medical Officer
- Taitel Haya, Director
- Ellis Sean, Director
- Yaacov-Garbeli Dana, Chief Financial Officer
- Galitzer Hillel, Chief Operating Officer
- Burshtein Gregory, Chief of R&D